ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,685Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1107

$1.58M Total Retail Price of All Prescriptions

Rank: 17 out of 1107

797 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 797 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 797 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 21,225 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,523 1,211 S3 1 1
WARFARIN SODIUM 1,129 1,042 2 15
OMEPRAZOLE 823 707 3 4
LEVOTHYROXINE SODIUM 733 700 4 3
FUROSEMIDE 630 583 5 7
SIMVASTATIN 612 537 6 5
LISINOPRIL 591 530 7 2
POTASSIUM CHLORIDE 442 360 8 14
CITALOPRAM HBR 373 313 9 17
ATENOLOL 351 284 10 19
AMLODIPINE BESYLATE 347 340 11 6
ATORVASTATIN CALCIUM 344 316 12 13
SERTRALINE HCL 303 283 13 20
PRAVASTATIN SODIUM 298 240 14 12
CYMBALTA 267 182 15 50
METFORMIN HCL 260 222 16 8
GABAPENTIN 246 202 17 9
ALBUTEROL SULFATE 242 234 18 144
PAROXETINE HCL 237 225 19 45
LOSARTAN POTASSIUM 234 223 20 29
CEFTRIAXONE 223 215 21 227
METOPROLOL TARTRATE 215 186 22 10
POLYETHYLENE GLYCOL 3350 211 188 23 46
CARVEDILOL 208 194 24 27
LEVEMIR FLEXPEN 200 186 25 213
RISPERIDONE 188 167 26 79
CLOPIDOGREL 187 161 27 28
FENTANYL 181 131 S2 28 105
ALLOPURINOL 175 147 29 36
DIVALPROEX SODIUM 172 138 30 96
PREDNISONE 171 149 31 40
DIGOXIN 170 164 32 52
NAMENDA 167 167 33 42
SPIRIVA 167 157 33 57
RISPERDAL CONSTA 161 161 35 263
METOPROLOL SUCCINATE 159 107 36 16
LIDOCAINE HCL 159 154 36 242
LOVASTATIN 155 143 38 55
RANITIDINE HCL 150 100 39 21
LEVOFLOXACIN 149 139 40 71
DONEPEZIL HCL 149 142 40 32
TRAMADOL HCL 140 111 42 26
MIRTAZAPINE 134 117 43 61
FLUTICASONE PROPIONATE 133 119 44 38
ESCITALOPRAM OXALATE 133 130 44 82
PANTOPRAZOLE SODIUM 133 126 44 30
NOVOLOG FLEXPEN 129 128 47 230
AZITHROMYCIN 128 110 48 35
ISOSORBIDE MONONITRATE ER 126 116 49 34
KLOR-CON M20 123 116 50 75
EXELON 122 114 51 103
JANUVIA 120 120 52 60
LANTUS 117 108 53 49
ZOLPIDEM TARTRATE 113 89 54 22
LYRICA 101 78 55 83
PLAVIX 101 91 55 39
FLUOXETINE HCL 100 54 57 47
ESTRADIOL 99 90 R 58 151
HYDROCHLOROTHIAZIDE 98 96 59 11
LIDODERM 98 88 59 140
SYNTHROID 97 68 61 70
SUCRALFATE 92 81 62 121
NITROGLYCERIN PATCH 91 77 63 184
PROMETHAZINE HCL 91 54 R 63 44
LACTULOSE 90 89 65 89
CLONIDINE HCL 88 74 66 53
DIOVAN 88 87 66 51
AMITRIPTYLINE HCL 87 57 R 68 48
BUSPIRONE HCL 87 74 68 107
NEXIUM 86 67 70 18
GENTAMICIN SULFATE 82 80 71 298
ADVAIR DISKUS 80 55 72 54
TRAZODONE HCL 80 58 72 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 65 74 88
NYSTATIN 77 67 75 110
HYDRALAZINE HCL 73 65 76 99
ALENDRONATE SODIUM 73 56 76 41
MORPHINE SULFATE ER 72 57 S2 78 156
MELOXICAM 72 70 78 25
VENLAFAXINE HCL 71 52 80 193
QUETIAPINE FUMARATE 71 54 80 94
BACLOFEN 71 26 80 133
ALPRAZOLAM 70 43 83 87
DOXAZOSIN MESYLATE 69 66 84 92
SINGULAIR 68 58 85 65
PHENYTOIN SODIUM EXTENDED 68 54 85 147
VERAPAMIL ER 68 64 85 113
TAMSULOSIN HCL 67 57 88 30
ENALAPRIL MALEATE 66 55 89 98
CIPROFLOXACIN HCL 64 54 90 59
SPIRONOLACTONE 64 49 90 72
CRESTOR 62 49 92 23
NIFEDIPINE ER 59 58 93 168
ACETIC ACID 59 32 93 334
METOCLOPRAMIDE HCL 58 46 95 116
RAMIPRIL 58 50 95 84
ACETAMINOPHEN-CODEINE 57 57 S3 97 120
IPRATROPIUM BROMIDE 56 40 98 246
ABILIFY 56 46 98 170
CARBIDOPA-LEVODOPA 56 56 98 122
GENERLAC 55 48 101 281
CLONIDINE 55 55 101 286
LIPITOR 55 48 101 109
OXYBUTYNIN CHLORIDE ER 54 54 104 179
CHLORTHALIDONE 54 42 104 175
MINOCYCLINE HCL 54 48 104 351
NOVOLOG 54 54 104 127
FENOFIBRATE 53 43 108 67
SEREVENT DISKUS 53 52 108 459
TRIAMTERENE-HCTZ 53 51 108 62
NIASPAN 53 47 108 125
GLUCAGEN 52 52 112 310
VENLAFAXINE HCL ER 52 46 112 117
DIOVAN HCT 51 42 114 106
PROCTOZONE-HC 51 49 114 473
BENAZEPRIL HCL 51 51 114 86
GLIMEPIRIDE 50 50 117 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.